Business Context and Reporting Period
Company: Core Scientific, Inc. (CORZ)
Filing Type: Form 8-K (Current Report)
Date of Report: June 12, 2024
Event: Regulation FD Disclosure regarding an investor and analyst day presentation.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure of a presentation rather than a financial statement.
Material Changes
No material financial changes or historical comparisons are detailed in the text of this filing. The report focuses on the release of forward-looking information contained in an attached investor presentation.
Guidance, Outlook, and Risks
Management Commentary: The company released an investor presentation on June 12, 2024. The filing explicitly states that the information in the presentation is furnished and not "filed" for purposes of Section 18 of the Exchange Act.
Forward-Looking Statements: The filing contains extensive cautionary notes regarding forward-looking statements. Key areas of focus include:
- Strategic relationship, agreements, and contemplated transactions with CoreWeave.
- Expected impacts on financial and operating results.
- Ability to deliver shareholder value and capitalize on additional opportunities.
Risks and Contingencies: Management highlighted that actual results may differ materially from expectations due to:
- Unanticipated difficulties or expenditures related to the CoreWeave relationship.
- Failure to realize anticipated financial or operational benefits.
- Disruptions to current plans and operations.
- Diversion of management attention.
- Adverse reactions from business, regulatory, or employee relationships.
- Termination of contracts with CoreWeave.
- Delays in required approvals and availability of government incentives.
- Legal proceedings, judgments, or settlements.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Investor Presentation) for specific financial projections and strategic details, noting that this exhibit is not deemed "filed."
- Verify the status and terms of the strategic relationship and agreements with CoreWeave.
- Assess the risks associated with the potential termination of contracts with CoreWeave.
- Monitor for updates on government incentives and required regulatory approvals mentioned in the risk factors.
- Check subsequent filings (10-K, 10-Q) for historical financial data not included in this 8-K.